VPS33B

protein-coding

VPS33B late endosome and lysosome associated

Gene summary

Vesicle mediated protein sorting plays an important role in segregation of intracellular molecules into distinct organelles. Genetic studies in yeast have identified more than 40 vacuolar protein sorting (VPS) genes involved in vesicle transport to vacuoles. This gene is a member of the Sec-1 domain family, and encodes the human ortholog of rat Vps33b which is homologous to the yeast class C Vps33 protein. The mammalian class C vacuolar protein sorting proteins are predominantly associated with late endosomes/lysosomes, and like their yeast counterparts, may mediate vesicle trafficking steps in the endosome/lysosome pathway. Mutations in this gene are associated with arthrogryposis-renal dysfunction-cholestasis syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]

MANE transcript

NM_018668.5

Inheritance

AR

ClinVar variants

P:64U:233B:80

Top phenotype

Keratoderma-ichthyosis-deafness syndrome, autosomal recessive; Cholestasis, progressive familial intrahepatic, 12; Arthrogryposis, renal dysfunction, and cholestasis 1

gnomAD constraint

pLI —, LoF o/e 0.71

Max pathogenic AF

—

Genomic locus

chr15:90,998,673-91,022,603

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~23.9 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

arthrogryposis, renal dysfunction, and cholestasis 1STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0008822

Submitter: PanelApp Australia

arthrogryposis, renal dysfunction, and cholestasis 1STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0008822

Submitter: Labcorp Genetics (formerly Invitae)

arthrogryposis-renal dysfunction-cholestasis syndromeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0017123

Submitter: Orphanet

arthrogryposis, renal dysfunction, and cholestasis 1DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0008822

Submitter: G2P

keratoderma-ichthyosis-deafness syndrome, autosomal recessiveMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0859278

Submitter: G2P

arthrogryposis, renal dysfunction, and cholestasis 1DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0008822

Submitter: ClinGen

VPS33B was first reported in relation to autosomal recessive arthrogryposis, renal dysfunction, and cholestasis 1 (ARC) in 2004 (Gissen P, et al., 2004, PMID: 15052268). The classical presentation of ARC includes congenital joint contractures, renal tubular dysfunction, and cholestasis. Additional features include ichthyosis, central nervous system malformation, platelet anomalies, and severe failure to thrive. At least 19 unique variants (mostly nonsense but also frameshift, splicing, start loss, and missense) have been reported in humans with Pathogenic classifications in ClinVar. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 9 probands in 2 publications (PMIDs: 15052268, 18853461), included in this curation. Additional evidence is available in the literature, however the maximum points for genetic evidence were reached. This gene-disease relationship is supported by its interaction with VIPAS39 (PMID: 20190753) and their function as part of a complex that interacts with an active form of RAB11A involved in apical membrane protein sorting, the alteration in mIMCD-3 cells confirming the role of VPS33B in regulating apical-basolateral polarity in the kidney consistent with the renal dysfunction seen in patients (PMID: 20190753), a zebrafish model recapitulating biliary abnormalities (PMID: 20190753), and a mouse model with collagen abnormalities identified in skin fibroblasts and tendons consistent with the characteristic ARC features of ichthyosis, arthrogryposis, osteopenia and bone fractures (PMID: 27435297) as well as a marked reduction in α-granule count and the presence of small granule-like structures in agreement with the platelet phenotype observed in ARC patients (PMID: 25947942). In summary VPS33B is definitively associated with autosomal recessive arthrogryposis, renal dysfunction, and cholestasis 1.

Clinical Genomic Database (CGD)

Keratoderma-ichthyosis-deafness syndrome, autosomal recessive; Cholestasis, progressive familial intrahepatic, 12; Arthrogryposis, renal dysfunction, and cholestasis 1AR

Manifestation: Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Gastrointestinal; Musculoskeletal; Renal

Intervention: Audiologic/Otolaryngologic; Cardiovascular; Gastrointestinal; Renal

Rationale: Individuals with Keratoderma-ichthyosis-deafness syndrome, autosomal recessive have been described with hearing impairment, and early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; Cholestasis, progressive familial intrahepatic has been described as involving early-onset hepatic dysfunction, and medical and surgical interventions have been described as beneficial in some individuals; Individuals with Arthrogryposis, renal dysfunction, and cholestasis 1 may have manifstations including hearing loss, cardiovascular anomalies, renal dysfunction, and cholestasis, and awareness may allow early diagnosis and medical or surgical management of these sequelae

Refs: 28017832; 30561130; 31479177Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to VPS33B variants in ClinVar

11 Conditions Cataloged
not providedTotal: 357
Arthrogryposis, renal dysfunction, and cholestasis 1Total: 164
Cholestasis, progressive familial intrahepatic, 12Total: 110
Keratoderma-ichthyosis-deafness syndrome, autosomal recessiveTotal: 107
Inborn genetic diseasesTotal: 88
VPS33B-related disorderTotal: 50
not specifiedTotal: 49
ThrombocytopeniaTotal: 2

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_018668.5. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
2
clinvar
8
clinvar
67
clinvar
5
clinvar
83
missense
3
clinvar
3
clinvar
213
clinvar
8
clinvar
227
nonsense
10
clinvar
5
clinvar
1
clinvar
16
start loss
0
frameshift
9
clinvar
10
clinvar
2
clinvar
21
splice donor/acceptor (+/-2bp)
8
clinvar
13
clinvar
9
clinvar
30
Total3133233755377

Highest pathogenic variant AF is 0.000018588029

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 46 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_018668.5RefSeqNP_061138.323MANE Select
ENST00000333371.8EnsemblENSP00000327650.423MANE Select
NM_001289148.1RefSeqNP_001276077.122Standard
NM_001289149.1RefSeqNP_001276078.120Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
vps33bDanio rerio

Structure: enterocyte

Quality: dilated

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Biological Process

  • vesicle docking involved in exocytosis
  • endosome organization
  • endosome to lysosome transport
  • protein transport
  • vesicle-mediated transport

Molecular Function

  • protein binding

Cellular Component

  • cytoplasm
  • lysosome
  • lysosomal membrane
  • late endosome
  • Golgi apparatus

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000333371
Coding exons
23
Length
24188
Individuals with no LoFs
125653
Homozygous LoFs
0
Heterozygous LoFs
95
Defined
125748
p
0.000378
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.3643143330.9440.00002054057
Missense (PolyPhen)99113.10.875331287
Synonymous0.3201201250.9640.000006961149
Loss of Function1.763143.50.7120.00000282477

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000180.00018rare
Latino/Admixed American0.000610.00061rare
Ashkenazi Jewish0.000790.00079rare
East Asian0.000490.00049rare
Finnish00.0absent
European (Non-Finnish)0.000390.00039rare
South Asian0.000200.00020rare
Other0.000650.00065rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: May play a role in vesicle-mediated protein trafficking to lysosomal compartments and in membrane docking/fusion reactions of late endosomes/lysosomes. Mediates phagolysosomal fusion in macrophages (PubMed:18474358). Proposed to be involved in endosomal maturation implicating VIPAS39. In epithelial cells, the VPS33B:VIPAS39 complex may play a role in the apical recycling pathway and in the maintenance of the apical-basolateral polarity (PubMed:20190753). Seems to be involved in the sorting of specific cargos from the trans-Golgi network to alpha-granule-destined multivesicular bodies (MVBs) promoting MVBs maturation in megakaryocytes (By similarity). {ECO:0000250|UniProtKB:P59016, ECO:0000269|PubMed:18474358, ECO:0000305|PubMed:20190753, ECO:0000305|PubMed:23918659}.;
Disease
DISEASE: Arthrogryposis, renal dysfunction and cholestasis syndrome 1 (ARCS1) [MIM:208085]: A multisystem disorder, characterized by neurogenic arthrogryposis multiplex congenita, renal tubular dysfunction and neonatal cholestasis with bile duct hypoplasia and low gamma glutamyl transpeptidase activity. Platelet dysfunction is common. {ECO:0000269|PubMed:15052268, ECO:0000269|PubMed:18853461, ECO:0000269|PubMed:20190753, ECO:0000269|PubMed:22753090, ECO:0000269|PubMed:23918659}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.118

Intolerance Scores

LoFtool
0.822
RVIS EVS
-0.53
RVIS percentile EVS
20.82

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.789

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.